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Editorial on the Research Topic
Role of Neutrophils in Inflammatory Diseases
Neutrophils are best known for their role in host defense against microbes (1). However, many
recent discoveries highlight the fact that neutrophils also act as key regulators of both acute and
chronic sterile inflammatory conditions (2). Neutrophils can mediate their functions through
different mechanisms, including generation of reactive oxygen species (ROS) and neutrophil
extracellular traps (NETs), and the release of a broad range of mediators, including cytokines,
alarmins, and proteases (1). A better knowledge of the mechanisms controlling these processes
might thus help design new therapeutic strategies for the treatment of inflammatory diseases.
This Research Topic brings together original and review articles that explore the role of
neutrophils and neutrophil-derived products in various inflammatory diseases, and assess some
molecular mechanisms through which these cells are activated in inflammatory conditions.
It is known that lipopolysaccharide (LPS) from gram negative bacteria can “prime” neutrophil
for ROS production in combination with other agonists. Liu et al. used pharmacological approaches
to show that the prolyl cys/trans isomerase Pin1 plays an important role in LPS-induced priming of
human neutrophils. These data suggest that Pin1 could be a therapeutic target in sepsis and other
diseases involving ROS generation by neutrophils.
Chiang et al. present an overview of the potential roles of neutrophils in psoriasis, a chronic
inflammatory skin disease in which high numbers of neutrophils are observed in skin lesions. Their
review focuses mostly on clinical observations, including evidence of neutrophil activation in skin
lesions, with generation of ROS and formation of NETs. The authors also discuss the potential
contribution of NETs in driving Th17 inflammation in psoriasis.
Lastly, the potential role of NETs in infectious and inflammatory diseases has emerged as a major
field of research (3, 4). Not surprisingly, several manuscripts of this special issue focus on the
mechanisms of NET formation, and on the role of NETs in various inflammatory conditions. Barbu
et al. describe a new method for the detection and quantification of histone H4 citrullination
(H4cit3) during NET formation using imaging flow cytometry (IFC). Using this method, the
authors quantify H4cit3 in human blood neutrophils stimulated with NET-triggering molecules.
They suggest that their method can be particularly suitable for studies looking at NETs as potential
biomarkers for diseases. The method is fast and requires only minimal handling of neutrophils,
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thereby reducing potential unspecific cell activation. However,
the authors also emphasize that detection limitations might be
associated with some stimuli.
Many infectious and inflammatory diseases are characterized
by an increase in vascular permeability. In a review article, Ma
et al. present a detailed overview of current knowledge on the
potential role of neutrophils in regulating vascular endothelial
permeability. The authors particularly focus on the role of NETs
and the molecular pathways leading to NET formation, and on
the potential role of neutrophil-derived extracellular vesicules,
which are heterogenous membrane-enveloped structures
released by many cell types, including neutrophils.
Fever is a hallmark of both infectious and inflammatory
diseases, and hyperthermia is known to increase neutrophil
recruitment to the affected sites. Keitelman et al. studied the
impact of hyperthermia on key neutrophil functions including
NET release, production of ROS, and release of pro-inflammatory
cytokines. The authors propose that fever that occurs during
bacterial infections might trigger an emergency response in
neutrophils in order to enhance some of their antimicrobial
functions, but could at the same time reduce their capacity to
release proinflammatory cytokines in order to limit potentially
damaging inflammatory processes.
Obama et al. investigate the mechanisms of neutrophil activation
in the context of cardiovascular diseases. The authors focused on the
effects of oxidatively modified low-density lipoprotein (oxLDL),
which are known as a risk factor for the progression of
cardiovascular diseases. They show that while oxLDL alone does
not induce NET formation, it enhances phorbol myristate acetate
(PMA)-induced release of NETs and myeloperoxidase (MPO). The
authors suggest that oxLDL may contribute to vascular endothelial
inflammation, at least in part by NET-dependent mechanisms.
Granger et al. review the available literature on the role of IgG
immune complexes (ICs) in triggering NET release through
activation of IgG Fc gamma receptors (FcgRs) on neutrophils.
They focus on two autoimmune diseases, systemic lupus
erythematosus in which NETs can be induced by DNA/anti-
DNA IgG ICs, and rheumatoid arthritis for which citrullinated
protein/anti-citrullinated protein IgG ICs might mediate NET
formation. In addition to autoimmunity, they also review
available data on the potential role of ICs-induced NETs in
anaphylaxis, a systemic and potentially lethal hypersensitivity
reaction. Finally, the authors discuss the potential applications of
NETs as biomarkers and therapeutic targets in these diseases.
Most of the aforementioned studies focus on the pro-
inflammatory and tissue-damaging potential of neutrophils.
However, it was reported that neutrophils also have important
regulatory functions, and might participate in the resolution of
inflammation (5). In this context, Egholm et al. review existing
literature on the regulatory effect of the receptor IL-4R (shared
by the cytokines IL-4 and IL-13) on neutrophils during type 2
immune responses. They highlight the fact that engagement of
IL-4R on neutrophils can inhibit several neutrophil effector
functions, including the formation of NETs. The authors thus
propose that, during type 2 immune responses as in other
immune responses, neutrophils are the first non-resident cells
to arrive at the site of inflammation, but that subsequent IL-4/IL-
13 signaling can rapidly shut off neutrophil effector functions to
prevent damage to healthy tissues.
Many tools and models are now available to study the role of
neutrophils during biological responses in vivo. However, each
model has its own advantages and limitations. In the review by
Stackowicz et al., the authors provide a side-by-side comparison
of the main existing genetic and pharmacological approaches to
assess the functions of neutrophils and neutrophil-derived
products in mice. The authors recommend that, given the
known or potential limitation(s) of each model, at least two
different approaches should be employed to legitimately
conclude on neutrophil functions.
Finally, illustrating the variety of models which can be used to
study neutrophils, the work by Degroote et al. focuses on primary
neutrophils from equine whole blood. The authors analyzed
these neutrophils by mass spectrometry and identified a total
of 2,032 proteins forming the whole proteome of these cells.
Furthermore, they identified a total of 58 or 207 proteins
differentially regulated after stimulation with interleukin-8 (IL-
8, also known as CXCL8) or PMA, respectively.
In conclusion, the papers included in this Research Topic
highlight the diverse role of neutrophils in the regulation of
inflammatory responses, and the potential of future therapies
targeting neutrophils or neutrophil-derived products for the
management of inflammatory diseases.
AUTHOR CONTRIBUTIONS
All authors listed have made a substantial, direct, and intellectual
contribution to the work and approved it for publication.
FUNDING
TM is supported by the FRFS-WELBIO (Walloon Excellence in
Life Sciences and Biotechnology; grant no. CR-2019s-04R), by
the Acteria Foundation and by an ERC Starting Grant (grant no.
ERC-StG-2018 IM-ID 801823). OB received funding by the
Swiss National Science Foundation (310030-172978), the
Hochspezialisierte Medizin Schwerpunkt Immunologie (HSM-
2-Immunologie), and the Clinical Research Priority Program
CYTIMM-Z of the University of Zurich. LR acknowledges
support from the French Institut National de la Santé et de la
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